[1] Yusof MF, Eltahir YM, Serhan WS, et al.Prevalence of Middle East respiratory syndrome coronavirus(MERS-CoV)in dromedary camels in Abu Dhabi Emirate, United Arab Emirates[J]. Virus Genes, 2015, 50(3):509-513. [2] Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia[J]. N Engl J Med, 2012, 367(19):1814-1820. [3] de Groot RJ, Baker SC, Baric RS, et al. Middle Eastrespiratory syndrome coronavirus(MERS-CoV):announcement of the Coronavirus Study Group[J]. J Virol, 2013, 87(14):7790-7792. [4] http://www. Who. int/csr/don/2014_05_15_mers/en/Middle East respiratory syndrome coronavirus(MERS- Co V)summary and literature update-as of 9 May 2014[R]. [5] Yang Y, Liu C, Du L, et al.Two mutations were critical for bat-to-human transmission of Middle East respiratory syndrome coronavirus[J]. J Virol, 2015, 89(17):9119-9123. [6] Yang Y, Du L, Liu C, et al.Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus[J]. Proc Natl Acad Sci USA, 2014, 111(34):12516-12521. [7] Mohd HA, Al-Tawfiq JA, Memish ZA.Middle East respiratory syndrome coronavirus(MERS-Co V)origin and animal reservoir[J]. J Virol, 2016, 13:87. [8] Cotton M, Lam TT, Watson SJ, et al.Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus[J]. Emerg Infect Dis, 2013, 19(5):736-742. [9] Li W, Moore MJ, Vasilieva N, et al.Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus[J]. Nature, 2003, 426(6965):450-454. [10] Raj VS, Mou H, Smits SL, et al.Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC[J]. Nature, 2013, 495(7440):251-254. [11] Li F.Receptor recognition mechanisms of coronaviruses:a decade of structural studies[J]. J Virol, 2015, 89(4):1954-1964. [12] Lu G, Hu Y, Wang Q, et al.Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26[J]. Nature, 2013, 500(7461):227-231. [13] Zhang N, Jiang S, Du L.Current advancements and potential strategies in the development of MERS-CoV vaccines[J]. Expert Rev Vaccines, 2014, 13(6):761-774. [14] Du L, Zhao G, Kou Z, et al.Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development[J]. J Virol, 2013, 87(17):9939-9942. [15] Song F, Fu XR, Provacia LB, et al.Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies[J]. J virol, 2013, 87(21):11950-11954. [16] Coleman CM, Liu YV, Mu H, et al.Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice[J]. Vaccine, 2014, 32(26):3169-3174. [17] Li F.Receptor recognition mechanisms of coronaviruses:a decade of structural studies[J]. J Virol, 2015, 89(4):1954-1964. [18] Gao J, Lu G, Qi J, et al.Structure of the fusion core and inhibition of fusion by a heptad-repeat peptide derived from the S protein of MERS-Co V[J]. J Virol, 2013, 87:13134-13140. [19] Wang N, Shi X, Jiang L, et al.Structure of MERS-Co V spike receptor binding domain complexed with human receptor DPP4[J]. Cell Res, 2013, 23(8):986-993. [20] Barlan A, Zhao J, Sarkar MK, et al.Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection[J]. J Virol, 2014, 88(9):4953-4961. [21] Van DN, Miazgowicz KL, Milne-Price S, et al.Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4[J]. J Virol, 2014, 88(16):9220-9232. [22] Wolff J A, Malone RW, Williams P, et al.Direct gene transfer into mouse muscle in vivo[J]. Science, 1990, 2(17):1465-1468. [23] Egan MA, Israel ZR.The use of cytokines and chemokines as genetic adjuvants for plasmid DNA vaccines[J]. Ciin Appl Immunol Rev, 2002, 2:255-287. [24] Pilling AM, Harman RM, Jones SA, et al.The assessment of local tolerance, acute toxicity, and DNA biodistribution following particle-mediated delivery of a DNA vaccine to minipigs[J]. Toxicol Pathol, 2002, 30(3):298-305. [25] Schroder AR, Shinn P, Chen H, et al.HIV21 integration in the human genome favors active genes and local hotspots[J]. Cell, 2002, 110(4):521-529. [26] Lewinskim K, Bushman FD.Retroviral DNA integration-mechanism and consequences[J]. Adv Genet, 2005, 55:147-181. |